Previous 10 | Next 10 |
Orthofix Medical (NASDAQ: OFIX ) now expects Q1 revenue in the range of $104M - $105M vs. a consensus of $106.55M. More news on: Orthofix Medical Inc., Healthcare stocks news, , Read more ...
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal healing products, today announced preliminary financial results for the first quarter ended March 31, 2020 and provided a business update. “While we work through these challenging and un...
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal healing products, today announced it has completed the acquisition of assets associated with the FITBONE ® intramedullary lengthening system for limb lengthening of the femur and tibia bones....
Orthofix Medical, Inc. (OFIX) Q4 2019 Earnings Conference Call February 24, 2020, 16:30 ET Company Participants Mark Quick - Senior Director, Business Development and Investor Relations Jon Serbousek - President, CEO & Director Douglas Rice - CFO & CAO Conference Call ...
Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company focused on musculoskeletal healing products, announces support for the continued U.S. Food and Drug Administration (FDA) Class III designation for Bone Growth Stimulators to ensure patient safety and therapy efficacy. The ...
Orthofix (NASDAQ: OFIX ): Q4 Non-GAAP EPS of $0.51 misses by $0.07 ; GAAP EPS of $0.60 misses by $0.23 . More news on: Orthofix Medical Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Fourth Quarter Highlights Net sales of $121.5 million, an increase of 0.3% compared to prior year period and 0.9% on a constant currency basis Kevin Kenny, an experienced spine executive, joins as Global Spine President FDA approval of next generation Bone Growth Therapy patie...
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the fourth quarter and fiscal 2019 after market close on Monday, February 24, 2020. Jon Serbousek, President a...
App designed to facilitate patient compliance and improve outcomes now captures Patient Reported Outcome Measures Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced the U.S. Food and Drug Administrat...
Transaction expands limb reconstruction portfolio Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal healing products, today announced an asset purchase agreement with Wittenstein SE, a privately-held German-based company, to acquire assets...
News, Short Squeeze, Breakout and More Instantly...
Orthofix Medical Inc. Company Name:
OFIX Stock Symbol:
NASDAQ Market:
Orthofix Medical Inc. Website:
Wednesday, August 14, 2024 at 2:30 pm Eastern Time Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the Company will participate in Canaccord Genuity's 44th Annual Growth Conference in Boston. Management is scheduled to pre...
Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Stephanie Walsh as Chief Human Resources Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240716004...
Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510(k) clearance and first U.S. implant of the Fitbone ™ Transport and Lengthening System. Used to treat large bone defects in the femur and tibia due to trauma, infectious or ma...